LumiraDx’s COVID-19 Antigen Test Expanded to Include Screening of Asymptomatic Individuals
LumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.
Read MorePosted by Chris Wolski | Nov 2, 2021 | Covid 19, POC Rapid Assays |
LumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.
Read MorePosted by Chris Wolski | Nov 2, 2021 | Miscellaneous |
Custom trailers can alleviate healthcare facility gaps during the pandemic and provide necessary care anywhere, anytime.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Covid 19 |
A trained dog’s sensitive nose can detect the presence of COVID-19 variants within a matter of seconds, offering an additional layer of screening protocol.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Covid 19, POC Rapid Assays |
Making diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MorePosted by Chris Wolski | Nov 1, 2021 | Hematology Instrumentation |
A wearable device that “reads” blood through the skin could reduce racial disparities in blood measurements.
Read More